Alpha 1 Biomedicals, SciClone news

ALBM said it will be unable to supply Thymosin alpha 1 to SCLN because ALBM's contract manufacturer, UCB Bioproducts SA of Belgium, has experienced lower yields and slower-than-expected high performance liquid chromatography.

Vincent Simmon, ALBM president and CEO, said the anticipated yields were 150-250 grams, but the actual yield has been about 60 grams. ...